Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Gouty | 1 | 2020 | 1 | 0.710 |
Why?
|
Panniculitis | 1 | 2020 | 3 | 0.710 |
Why?
|
Skin Diseases, Vascular | 3 | 2018 | 3 | 0.500 |
Why?
|
Dermatologic Agents | 2 | 2008 | 6 | 0.500 |
Why?
|
Skin Diseases | 6 | 2001 | 25 | 0.480 |
Why?
|
Skin | 10 | 2018 | 99 | 0.470 |
Why?
|
Vasculitis | 3 | 2018 | 27 | 0.430 |
Why?
|
Skin Neoplasms | 8 | 2001 | 66 | 0.420 |
Why?
|
Sweet Syndrome | 3 | 2006 | 3 | 0.410 |
Why?
|
Dapsone | 2 | 2008 | 3 | 0.340 |
Why?
|
Lipectomy | 1 | 2009 | 1 | 0.330 |
Why?
|
Back | 1 | 2009 | 2 | 0.330 |
Why?
|
Lipomatosis | 1 | 2009 | 3 | 0.330 |
Why?
|
Abdomen | 1 | 2009 | 8 | 0.330 |
Why?
|
Extremities | 1 | 2009 | 23 | 0.320 |
Why?
|
Glycogen Storage Disease Type I | 1 | 2008 | 1 | 0.320 |
Why?
|
Acne Vulgaris | 1 | 2008 | 3 | 0.320 |
Why?
|
Anemia, Hemolytic | 1 | 2008 | 4 | 0.320 |
Why?
|
Lymphoma | 3 | 2007 | 30 | 0.320 |
Why?
|
Drug Eruptions | 2 | 2007 | 8 | 0.300 |
Why?
|
Pseudolymphoma | 1 | 2007 | 1 | 0.280 |
Why?
|
Hand Dermatoses | 1 | 2006 | 1 | 0.260 |
Why?
|
Diagnosis, Differential | 9 | 2018 | 341 | 0.260 |
Why?
|
Pyoderma Gangrenosum | 1 | 2006 | 2 | 0.260 |
Why?
|
Humans | 36 | 2020 | 25692 | 0.260 |
Why?
|
Thrombomodulin | 2 | 2001 | 2 | 0.220 |
Why?
|
Paraneoplastic Syndromes | 2 | 2000 | 7 | 0.220 |
Why?
|
Meningococcal Infections | 1 | 2001 | 1 | 0.200 |
Why?
|
Receptors, Cell Surface | 1 | 2001 | 37 | 0.190 |
Why?
|
Blood Coagulation Factors | 1 | 2001 | 19 | 0.190 |
Why?
|
Male | 15 | 2020 | 13917 | 0.190 |
Why?
|
Tretinoin | 2 | 1994 | 13 | 0.190 |
Why?
|
Antimalarials | 1 | 2001 | 5 | 0.180 |
Why?
|
Hemangiosarcoma | 1 | 2001 | 8 | 0.180 |
Why?
|
Facial Dermatoses | 1 | 2000 | 1 | 0.180 |
Why?
|
Myeloproliferative Disorders | 1 | 2000 | 3 | 0.180 |
Why?
|
Platelet Aggregation | 1 | 2000 | 6 | 0.180 |
Why?
|
Adult | 9 | 2020 | 7336 | 0.180 |
Why?
|
Thrombophilia | 1 | 2000 | 6 | 0.180 |
Why?
|
Antiphospholipid Syndrome | 1 | 2000 | 4 | 0.180 |
Why?
|
Hematologic Diseases | 2 | 1990 | 9 | 0.170 |
Why?
|
Disease | 1 | 1998 | 5 | 0.160 |
Why?
|
Biopsy | 6 | 2006 | 199 | 0.150 |
Why?
|
Female | 16 | 2008 | 14273 | 0.130 |
Why?
|
Adolescent | 5 | 2009 | 2076 | 0.130 |
Why?
|
Leg Ulcer | 2 | 1998 | 4 | 0.130 |
Why?
|
Scleroderma, Localized | 3 | 1998 | 5 | 0.120 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1994 | 4 | 0.110 |
Why?
|
Purpura | 1 | 1994 | 2 | 0.110 |
Why?
|
Middle Aged | 9 | 2008 | 8403 | 0.110 |
Why?
|
Syndrome | 3 | 2009 | 69 | 0.100 |
Why?
|
Child | 4 | 2008 | 1277 | 0.100 |
Why?
|
Immunoglobulin A | 2 | 1989 | 13 | 0.100 |
Why?
|
Leukapheresis | 1 | 1991 | 1 | 0.090 |
Why?
|
Photochemotherapy | 1 | 1991 | 3 | 0.090 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 1991 | 5 | 0.090 |
Why?
|
Candidiasis, Cutaneous | 1 | 2010 | 1 | 0.090 |
Why?
|
Neutrophils | 2 | 2006 | 89 | 0.090 |
Why?
|
Lupus Erythematosus, Discoid | 2 | 1987 | 9 | 0.090 |
Why?
|
Hyperplasia | 1 | 2009 | 17 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2008 | 63 | 0.080 |
Why?
|
Protein C | 2 | 2001 | 10 | 0.080 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 1988 | 11 | 0.080 |
Why?
|
Hemoglobins | 1 | 2008 | 72 | 0.080 |
Why?
|
Xanthomatosis | 3 | 1998 | 3 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2008 | 396 | 0.070 |
Why?
|
Sarcoma, Kaposi | 1 | 1987 | 3 | 0.070 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1987 | 33 | 0.070 |
Why?
|
Aged | 7 | 2006 | 8501 | 0.070 |
Why?
|
Paraproteinemias | 1 | 1986 | 6 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 1986 | 18 | 0.060 |
Why?
|
Fasciitis | 1 | 1985 | 1 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2006 | 68 | 0.060 |
Why?
|
Eosinophilia | 1 | 1985 | 35 | 0.060 |
Why?
|
Young Adult | 1 | 2008 | 1855 | 0.050 |
Why?
|
Endothelium | 1 | 2001 | 12 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 1998 | 180 | 0.050 |
Why?
|
Quinacrine | 1 | 2001 | 1 | 0.050 |
Why?
|
Hemangioendothelioma | 1 | 2001 | 2 | 0.050 |
Why?
|
Chloroquine | 1 | 2001 | 6 | 0.050 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2000 | 1 | 0.050 |
Why?
|
Protein S Deficiency | 1 | 2000 | 2 | 0.050 |
Why?
|
Budd-Chiari Syndrome | 1 | 2000 | 1 | 0.040 |
Why?
|
Capillaries | 1 | 2000 | 11 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2001 | 59 | 0.040 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2000 | 24 | 0.040 |
Why?
|
Bone Marrow | 1 | 2000 | 79 | 0.040 |
Why?
|
Erythema Multiforme | 1 | 1998 | 1 | 0.040 |
Why?
|
Erythema Nodosum | 1 | 1998 | 1 | 0.040 |
Why?
|
Rosacea | 1 | 1998 | 1 | 0.040 |
Why?
|
Dermatitis, Seborrheic | 1 | 1998 | 1 | 0.040 |
Why?
|
Tinea Versicolor | 1 | 1998 | 1 | 0.040 |
Why?
|
Flushing | 1 | 1998 | 3 | 0.040 |
Why?
|
Vitiligo | 1 | 1998 | 2 | 0.040 |
Why?
|
Stevens-Johnson Syndrome | 1 | 1998 | 2 | 0.040 |
Why?
|
Porphyria Cutanea Tarda | 1 | 1998 | 3 | 0.040 |
Why?
|
Cellulitis | 1 | 1998 | 10 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 1989 | 55 | 0.040 |
Why?
|
Thyroid Diseases | 1 | 1998 | 8 | 0.040 |
Why?
|
Scleroderma, Systemic | 1 | 1998 | 8 | 0.040 |
Why?
|
Dermatology | 1 | 1998 | 5 | 0.040 |
Why?
|
Dermatomyositis | 1 | 1998 | 12 | 0.040 |
Why?
|
Sarcoidosis | 1 | 1998 | 14 | 0.040 |
Why?
|
Diabetes Complications | 1 | 1998 | 57 | 0.040 |
Why?
|
Prognosis | 1 | 2001 | 739 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2018 | 28 | 0.040 |
Why?
|
Plasmacytoma | 2 | 1989 | 6 | 0.040 |
Why?
|
Necrosis | 3 | 2000 | 25 | 0.040 |
Why?
|
Consensus | 1 | 2018 | 90 | 0.040 |
Why?
|
Glomerulonephritis, IGA | 1 | 1997 | 5 | 0.040 |
Why?
|
Primary Health Care | 1 | 1998 | 91 | 0.040 |
Why?
|
Leukemic Infiltration | 1 | 1994 | 1 | 0.030 |
Why?
|
Photopheresis | 1 | 1994 | 1 | 0.030 |
Why?
|
Erythema | 1 | 1994 | 2 | 0.030 |
Why?
|
Keratinocytes | 1 | 1994 | 12 | 0.030 |
Why?
|
Risk Factors | 1 | 2000 | 2224 | 0.030 |
Why?
|
Heart Transplantation | 1 | 1994 | 29 | 0.030 |
Why?
|
Graft Rejection | 1 | 1994 | 63 | 0.030 |
Why?
|
Hemorrhage | 1 | 1994 | 75 | 0.030 |
Why?
|
Mycosis Fungoides | 1 | 1992 | 5 | 0.030 |
Why?
|
Lipoma | 1 | 1991 | 5 | 0.020 |
Why?
|
Hemangioma | 1 | 1991 | 6 | 0.020 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 1990 | 1 | 0.020 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 1 | 1990 | 3 | 0.020 |
Why?
|
Granuloma | 2 | 1992 | 14 | 0.020 |
Why?
|
Hemoglobinopathies | 1 | 1990 | 1 | 0.020 |
Why?
|
Hemoglobins, Abnormal | 1 | 1990 | 1 | 0.020 |
Why?
|
Histiocytosis, Langerhans-Cell | 2 | 1988 | 2 | 0.020 |
Why?
|
Leukemia | 1 | 1989 | 4 | 0.020 |
Why?
|
Histiocytic Sarcoma | 1 | 1989 | 3 | 0.020 |
Why?
|
Bromocriptine | 1 | 1989 | 5 | 0.020 |
Why?
|
Basement Membrane | 1 | 1988 | 10 | 0.020 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1988 | 1 | 0.020 |
Why?
|
Transfusion Reaction | 1 | 1988 | 6 | 0.020 |
Why?
|
Prednisone | 1 | 1988 | 58 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2010 | 588 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1989 | 102 | 0.020 |
Why?
|
Isotretinoin | 1 | 1987 | 6 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 1987 | 11 | 0.020 |
Why?
|
Immune Tolerance | 1 | 1987 | 12 | 0.020 |
Why?
|
Risk | 1 | 1987 | 190 | 0.020 |
Why?
|
Mast Cells | 1 | 1986 | 16 | 0.020 |
Why?
|
Myxedema | 1 | 1986 | 1 | 0.020 |
Why?
|
Purpura, Hyperglobulinemic | 1 | 1986 | 1 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 1986 | 3 | 0.020 |
Why?
|
Amyloidosis | 1 | 1986 | 24 | 0.020 |
Why?
|
Immunoglobulins | 1 | 1986 | 16 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1986 | 26 | 0.020 |
Why?
|
Rheumatoid Factor | 1 | 1985 | 5 | 0.020 |
Why?
|
Antibodies, Antinuclear | 1 | 1985 | 12 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 1987 | 120 | 0.020 |
Why?
|
Seizures | 1 | 1985 | 58 | 0.020 |
Why?
|
Epidermis | 2 | 1994 | 6 | 0.010 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2000 | 9 | 0.010 |
Why?
|
Forecasting | 1 | 1998 | 92 | 0.010 |
Why?
|
Cell Differentiation | 1 | 1994 | 127 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1994 | 284 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 1994 | 248 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1994 | 495 | 0.010 |
Why?
|
Giant Cells | 1 | 1992 | 2 | 0.010 |
Why?
|
Histiocytes | 1 | 1992 | 3 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1992 | 73 | 0.010 |
Why?
|
Lymphocytes | 1 | 1992 | 57 | 0.010 |
Why?
|
Eosinophils | 1 | 1992 | 44 | 0.010 |
Why?
|
Desmin | 1 | 1991 | 1 | 0.010 |
Why?
|
Factor VIIIa | 1 | 1991 | 1 | 0.010 |
Why?
|
S100 Proteins | 1 | 1991 | 4 | 0.010 |
Why?
|
Ear, External | 1 | 1991 | 2 | 0.010 |
Why?
|
Myoglobin | 1 | 1991 | 2 | 0.010 |
Why?
|
Ear Neoplasms | 1 | 1991 | 7 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1991 | 341 | 0.010 |
Why?
|
Hyperprolactinemia | 1 | 1989 | 1 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1988 | 49 | 0.000 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 1988 | 1 | 0.000 |
Why?
|
Eye Diseases | 1 | 1988 | 7 | 0.000 |
Why?
|
Brain Diseases | 1 | 1988 | 61 | 0.000 |
Why?
|
Langerhans Cells | 1 | 1986 | 1 | 0.000 |
Why?
|
Urticaria Pigmentosa | 1 | 1986 | 1 | 0.000 |
Why?
|
Urticaria | 1 | 1986 | 3 | 0.000 |
Why?
|
Staining and Labeling | 1 | 1986 | 16 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1986 | 61 | 0.000 |
Why?
|